Clinical Trials Browser

Phase 2 × Head and Neck Neoplasms × Celecoxib × Clear all

Squamous Cell Carcinoma of Head and Neck, Head and Neck Neoplasms, Tongue Neoplasms

NCT00052611 2018-03-29

Celecoxib in Preventing Cancer in Patients With Oral Leukoplakia and/or Head and Neck Dysplasia

Head and Neck Neoplasms, Hypopharyngeal Neoplasms, Laryngeal Neoplasms, Mouth Neoplasms, Nasopharyngeal Neoplasms, Oropharyngeal Neoplasms, Salivary Gland Neoplasms

NCT00698204 2014-06-05

Cox-2 Inhibition in Radiation-induced Oral Mucositis

Phase 2 Completed

43 enrolled 10 charts

Head & NeckOther

Head and Neck Neoplasms, Stomatitis, Mucositis

NCT00061906 2014-02-11

Celecoxib in Treating Patients With Progressive Metastatic Differentiated Thyroid Cancer

Phase 2 Completed

25 enrolled

EndocrineHead & Neck

Thyroid Cancer, Papillary, Head and Neck Neoplasms, Thyroid Neoplasms, Adenocarcinoma, Follicular

NCT00589186 2013-12-18

Vaccine Therapy and Celecoxib in Treating Patients With Metastatic Nasopharyngeal Cancer

Phase 2 Unknown

35 enrolled

Head & Neck

Head and Neck Neoplasms

NCT00101335 2013-07-11

Celecoxib in Preventing Head and Neck Cancer in Patients With Oral Leukoplakia

Phase 2 Completed

Head & NeckOther neoplasm

Head and Neck Neoplasms, Hypopharyngeal Neoplasms, Leukoplakia, Oral, Mouth Neoplasms, Nasopharyngeal Neoplasms, Oropharyngeal Neoplasms, Precancerous Conditions, Tongue Neoplasms

NCT00014404 2013-01-16

Celecoxib in Treating Patients With Precancerous Lesions of the Mouth

Phase 2 Completed

Head & Neck

Head and Neck Neoplasms, Mouth Neoplasms

NCT00527982 2012-12-06

Celecoxib as Adjuvant Biologic Therapy in Patients With Head and Neck and Lung Cancer

Phase 2 Terminated

1 enrolled 2 charts

Head & NeckThoracic

Carcinoma, Non-Small-Cell Lung, Head and Neck Neoplasms, Lung Neoplasms

NCT00058006 2012-06-11

Celecoxib in Treating Patients With Early-Stage Head and Neck Cancer or Non-Small Cell Lung Cancer

Phase 2 Completed

Head & NeckThoracic

Squamous Cell Carcinoma of Head and Neck, Carcinoma, Non-Small-Cell Lung, Head and Neck Neoplasms, Lung Neoplasms, Salivary Gland Neoplasms

Clinical Trials

ERLO-XIB

Celecoxib in Preventing Cancer in Patients With Oral Leukoplakia and/or Head and Neck Dysplasia

Cox-2 Inhibition in Radiation-induced Oral Mucositis

Celecoxib in Treating Patients With Progressive Metastatic Differentiated Thyroid Cancer

Vaccine Therapy and Celecoxib in Treating Patients With Metastatic Nasopharyngeal Cancer

Celecoxib in Preventing Head and Neck Cancer in Patients With Oral Leukoplakia

Celecoxib in Treating Patients With Precancerous Lesions of the Mouth

Celecoxib as Adjuvant Biologic Therapy in Patients With Head and Neck and Lung Cancer

Celecoxib in Treating Patients With Early-Stage Head and Neck Cancer or Non-Small Cell Lung Cancer